| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |